Benzinga Rankings give you vital metrics on any stock – anytime.
Explore Cardiff Oncology stock price, quotes, charts and forecasts with Benzinga. Stay updated on market trends for CRDF.
You can purchase shares of Cardiff Oncology (NASDAQ:CRDF) through any online brokerage.
Other companies in Cardiff Oncology’s space includes: Innate Pharma (NASDAQ:IPHA), Humacyte (NASDAQ:HUMA), Voyager Therapeutics (NASDAQ:VYGR), Tevogen Bio Holdings (NASDAQ:TVGN) and Sangamo Therapeutics (NASDAQ:SGMO).
Cardiff Oncology has a consensus price target of $10.80.
The stock price for Cardiff Oncology (NASDAQ: CRDF) is $3.0298 last updated April 25, 2025 at 6:23 PM EDT.
There are no upcoming dividends for Cardiff Oncology.
Cardiff Oncology’s Q1 earnings are confirmed for Friday, May 9, 2025.
There is no upcoming split for Cardiff Oncology.
Cardiff Oncology is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.